July 27, 2024 10:34 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Paris Olympics: Lady Gaga rocks opening ceremony with her jaw-dropping act | Rahul Gandhi stops at a cobbler's shop on his way back to Lucknow | Priyanka Gandhi rips into Israeli govt over war on Gaza, says 'their actions are unacceptable' | Barack Obama endorses Kamala Harris for US Presidency | France: Rail network hit by 'malicious' arson attacks ahead of Paris Olympics
Sanofi collaborates with Dr. Reddy’s Labs to promote and distribute its vaccine brands in India

Sanofi collaborates with Dr. Reddy’s Labs to promote and distribute its vaccine brands in India

New Delhi: Hyderabad-based pharmaceutical major Dr. Reddy’s Laboratories Limited (DRL) on Wednesday announced an exclusive partnership with Sanofi Healthcare India Private Limited to promote and distribute Sanofi’s vaccine brands across the country.

Dr Reddy's Q2 Result: Consolidated net profit jumps 30 pc

Dr Reddy's Q2 Result: Consolidated net profit jumps 30 pc

Mumbai/IBNS: Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) Friday declared a year-on-year (YoY) rise in consolidated net profit at Rs 992 crore, up 30 per cent.

Dr Reddy's Labs launches Trientine Hydrochloride Capsules in US Market

Dr Reddy's Labs launches Trientine Hydrochloride Capsules in US Market

Mumbai/UNI Pharma Major Dr Reddy's Laboratories on Friday announced the US launch of Trientine Hydrochloride Capsules a therapeutically equivalent generic version of Syprine (trientine hydrochloride) Capsules, approved by the US Food and Drug Administration (USFDA).